Giani Marco, Redaelli Simone, Siragusa Antonio, Fumagalli Benedetta, Rona Roberto, Foti Giuseppe
School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.
Emergency and Intensive Care, Azienda Socio Sanitaria Territoriale di Monza, 20900 Monza (MB), Italy.
Membranes (Basel). 2021 Feb 28;11(3):172. doi: 10.3390/membranes11030172.
Veno-venous extracorporeal membrane oxygenation (V-V ECMO) in acute respiratory distress syndrome (ARDS) improves gas exchange and allows lung rest, thus minimizing ventilation-induced lung injury. In the last forty years, a major technological and clinical improvement allowed to dramatically improve the outcome of patients treated with V-V ECMO. However, many aspects of the care of patients on V-V ECMO remain debated. In this review, we will focus on main issues and controversies on caring of ARDS patients on V-V ECMO support. Particularly, the indications to V-V ECMO and the feasibility of a less invasive extracorporeal carbon dioxide removal will be discussed. Moreover, the controversies on management of mechanical ventilation, prone position and sedation will be explored. In conclusion, we will discuss evidences on transfusions and management of anticoagulation, also focusing on patients who undergo simultaneous treatment with ECMO and renal replacement therapy. This review aims to discuss all these clinical aspects with an eye on future directions and perspectives.
静脉-静脉体外膜肺氧合(V-V ECMO)用于急性呼吸窘迫综合征(ARDS)可改善气体交换并使肺得到休息,从而将通气引起的肺损伤降至最低。在过去四十年中,一项重大的技术和临床进展使接受V-V ECMO治疗的患者的预后得到了显著改善。然而,V-V ECMO患者护理的许多方面仍存在争议。在本综述中,我们将聚焦于V-V ECMO支持下ARDS患者护理的主要问题和争议。特别是,将讨论V-V ECMO的适应证以及微创体外二氧化碳清除的可行性。此外,还将探讨机械通气管理、俯卧位和镇静方面的争议。最后,我们将讨论输血和抗凝管理的证据,同时关注接受ECMO和肾脏替代疗法同步治疗的患者。本综述旨在着眼于未来方向和前景来讨论所有这些临床方面。